https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 D. russelii venom mediates vasodilatation of resistance like arteries via activation of Kv and KCa channels https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45245 Daboia russelii) venom causes a range of clinical effects in humans. Hypotension is an uncommon but severe complication of Russell’s viper envenoming. The mechanism(s) responsible for this effect are unclear. In this study, we examined the cardiovascular effects of Sri Lankan D. russelii venom in anaesthetised rats and in isolated mesenteric arteries. D. russelii venom (100 µg/kg, i.v.) caused a 45 ± 8% decrease in blood pressure within 10 min of administration in anaesthetised (100 µg/kg ketamine/xylazine 10:1 ratio, i.p.) rats. Venom (1 ng/mL–1 µg/mL) caused concentration-dependent relaxation (EC50 = 145.4 ± 63.6 ng/mL, Rmax = 92 ± 2%) in U46619 pre-contracted rat small mesenteric arteries mounted in a myograph. Vasorelaxant potency of venom was unchanged in the presence of the nitric oxide synthase inhibitor, L-NAME (100 µM), or removal of the endothelium. In the presence of high K+ (30 mM), the vasorelaxant response to venom was abolished. Similarly, blocking voltage-dependent (Kv: 4-aminopryidine; 1000 µM) and Ca2+-activated (KCa: tetraethylammonium (TEA; 1000 µM); SKCa: apamin (0.1 µM); IKCa: TRAM-34 (1 µM); BKCa; iberiotoxin (0.1 µM)) K+ channels markedly attenuated venom-induced relaxation. Responses were unchanged in the presence of the ATP-sensitive K+ channel blocker glibenclamide (10 µM), or H1 receptor antagonist, mepyramine (0.1 µM). Venom-induced vasorelaxtion was also markedly decreased in the presence of the transient receptor potential cation channel subfamily V member 4 (TRPV4) antagonist, RN-1734 (10 µM). In conclusion, D. russelii-venom-induced hypotension in rodents may be due to activation of Kv and KCa channels, leading to vasorelaxation predominantly via an endothelium-independent mechanism. Further investigation is required to identify the toxin(s) responsible for this effect.]]> Wed 26 Oct 2022 19:42:29 AEDT ]]> Tyrosine hydroxylase phosphorylation in catecholaminergic brain regions: a marker of activation following acute hypotension and glucoprivation https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:15128 Wed 11 Apr 2018 12:22:53 AEST ]]> Noradrenaline in preterm infants with cardiovascular compromise https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29936 Wed 09 Feb 2022 15:53:01 AEDT ]]> Hypotensive and vascular relaxant effects of phospholipase A₂ toxins from Papuan taipan (Oxyuranus scutellatus) venom https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:14546 Sat 24 Mar 2018 08:18:49 AEDT ]]> Expression of genes of the cardiac and renal renin-angiotensin systems in preterm piglets: is this system a suitable target for therapeutic intervention? https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27954 Sat 24 Mar 2018 07:38:46 AEDT ]]> What inotrope and why? https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44135 Sat 08 Oct 2022 12:36:23 AEDT ]]>